Beryl Drugs share news, announcements and annual reports
BSE: 524606Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹25.00.
30 Oct: open ₹27.00, high ₹27.00, low ₹23.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13 Cr4,587th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.79
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,166
Beryl Drugs share news and announcements
572 announcements, routine notices left out, newest first. Page 3 of 12.
Aug 2025
7 Aug · Results
Jul 2025
29 Jul · Board meeting
Meeting on 7 Aug 2025: quarterly results5 Jul · Compliance-57 (5) : intimation after the end of quarter
May 2025
30 May · Results
30 May · Board meeting
19 May · Board meeting
Meeting on 30 May 2025: audited results
Apr 2025
12 Apr · COMPLIANCE CERTIFICATE UNDER REGULATION 40(9)
9 Apr · COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31ST MARCH, 2025
9 Apr · Compliance-57 (5) : intimation after the end of quarter
Mar 2025
3 Mar · Results
Feb 2025
8 Feb · Results
Jan 2025
31 Jan · Board meeting
Meeting on 8 Feb 2025: quarterly results7 Jan · Compliance-57 (5) : intimation after the end of quarter
Nov 2024
13 Nov · Results
5 Nov · Board meeting
Meeting on 13 Nov 2024: quarterly results
Oct 2024
5 Oct · Compliance-57 (5) : intimation after the end of quarter
Sep 2024
30 Sep · Meeting
30 Sep · Meeting
3 Sep · Meeting
3 Sep · Board meeting
Aug 2024
26 Aug · Board meeting
Meeting on 3 Sep 2024: annual general meeting9 Aug · Board meeting
Jul 2024
31 Jul · Board meeting
Meeting on 9 Aug 2024: quarterly results8 Jul · Compliance-57 (5) : intimation after the end of quarter
May 2024
30 May · Results
30 May · Board meeting
23 May · Board meeting
Meeting on 30 May 2024: audited results
Apr 2024
20 Apr · Board meeting
17 Apr · COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31.03.2024
12 Apr · Board meeting
Meeting on 20 Apr 2024